SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Urology Consultation — Hubert H. Humphrey — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Hubert H. Humphrey |
|---|
| Date of birth | 1911-05-27 |
|---|
| Identifiers | MRN HR-ML022-SYN-TD; SSN (made up) 000-22-8047 |
|---|
| Document date | 1977-02-03 |
|---|
| Author | Elaine Kowalczyk, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
Man of 65, three months after radical cystoprostatectomy with an ileal conduit at a cancer center for multifocal urothelial carcinoma with carcinoma in situ, pT2a N0, margins negative. Please share his survivorship surveillance close to home, review his stoma, and set the metabolic monitoring plan. [S]
Urgency: Routine, within four weeks. [S]
Questions for the consultant:
- Is any adjuvant treatment indicated for pT2a N0 disease with negative margins?
- What surveillance imaging and tests does he need, at what intervals, and which should primary care arrange?
- How should his appliance leaks and peristomal skin be managed, and which stoma complications should we watch for?
- What kidney and metabolic monitoring does the ileal conduit need (creatinine, acid-base, vitamin B12), and when should we treat?
- How should we interpret urine findings with a conduit, and when should infection be treated?
- Does the remaining urethra need surveillance?
History of Present Illness
Mr. Humphrey is seen at the request of Dr. Brandvold four months after radical cystoprostatectomy with an ileal conduit. His bladder history goes back many years: benign growths, then possibly cancerous tissue treated with intravesical thiotepa and pelvic radiation, and then recurrent multifocal tumors with carcinoma in situ in a small irradiated bladder, which led to early cystectomy. He has recovered well and works full time. For three weeks the appliance has leaked about twice a week at night, and the skin below the stoma is sore. He has had no fever, flank pain, or blood in the urine. Erections have not returned since surgery. He is independent in his stoma care. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Hubert Horatio Humphrey Jr. was born on 27 May 1911 in Wallace, South Dakota. [D]
- Humphrey served in the U.S. Senate from Minnesota from 1949 to 1964, as vice president from 1965 to 1969, and again in the Senate from 1971 until his death. [D]
- Humphrey sought medical advice in 1967 for blood in his urine; some doctors suspected bladder cancer, others disagreed, and he was not treated. In 1968 doctors found and removed several pinhead-size nonmalignant growths from his bladder. In 1994 researchers reported a p53 gene mutation in bladder cells from a 1967 urine sample of his. [D]
- In 1973 doctors found possibly cancerous tissue in his bladder and treated it with thiotepa and X-ray therapy, given five minutes a day for five weeks. [D]
- After three years free of cancer, an examination at the National Naval Medical Center in Bethesda for symptoms of a urinary tract infection found a low-grade malignancy, and in October 1976 a six-hour radical cystectomy at Memorial Sloan-Kettering Cancer Center removed his bladder, prostate, lymph nodes, the fatty tissue around the bladder, and part of the urethra; the ureters were joined to a conduit made from a segment of small intestine, brought out to an opening on the skin to the right of the navel and drained into a bag. The nodes were to be examined for spread, and an experimental two-drug chemotherapy might be offered. [D]
- He resumed his Senate duties in January 1977, serving as deputy president pro tempore from January 5, 1977. [D]
2 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Urothelial carcinoma of the bladder, multifocal, with carcinoma in situ, pT2a pN0 (0 of 18 nodes), margins negative, treated by radical cystoprostatectomy with an ileal conduit; no evidence of disease; under surveillance; synthetic modern detail linked to his documented bladder cancer | active | confirmed |
Z85.51 | S — Synthetic grade, stage, node count, and margins; the bladder growths, the earlier thiotepa and X-ray therapy, the low-grade malignancy, and the radical cystectomy with a small-intestine conduit are documented (D). Z85.51 is used because the tumor has been removed and no further treatment is directed at it. |
| Ileal conduit urostomy, right lower abdomen | active | confirmed |
Z93.6 | S — The small-intestine conduit and the stoma to the right of the navel are documented (D); the coding and the stoma findings are synthetic. |
| Acquired absence of the bladder and part of the urethra after radical cystectomy | active | confirmed |
Z90.6 | S — Documented operation (D); synthetic coding. |
| Acquired absence of the prostate after cystoprostatectomy | active | confirmed |
Z90.79 | S — Documented operation (D); synthetic coding. |
| Personal history of pelvic radiation for bladder tumor, with earlier intravesical thiotepa | active | confirmed |
Z92.3 | S — The thiotepa and X-ray therapy are documented (D); the coding and their relevance to the modern episode are synthetic. |
Physical Exam
Vital signs recorded on 1977-02-03; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|
| General | Well |
| Abdomen | Soft; healed midline incision; no incisional hernia |
| Stoma | Right lower abdomen; pink and moist; 28 mm, budded about 1.5 cm; moist erythema in a 1 cm band below the stoma without satellite lesions; a skin crease below the stoma when sitting; no parastomal bulge on coughing |
| Lymph nodes | No inguinal nodes |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 1977-02-03 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | | | S |
Assessment
- Urothelial carcinoma of the bladder, pT2a pN0, margins negative, after radical cystoprostatectomy (Z85.51). Organ-confined, node-negative disease. Upstaging from non-muscle-invasive disease at resection to pT2a at cystectomy is common, which is one reason early cystectomy is offered for high-risk disease that recurs after intravesical therapy, especially in an irradiated bladder. Adjuvant cisplatin-based chemotherapy or immunotherapy is offered for pT3 to pT4 or node-positive disease; for pT2a N0 with negative margins, the benefit does not justify the toxicity, and none is recommended. The main risks are recurrence in the pelvis or at distant sites and a new tumor in the upper tracts or the urethra. [S]
- Ileal conduit urostomy with appliance leaks and moisture dermatitis (Z93.6). The leaks come from a skin crease below the stoma when he sits, which a flat wafer cannot seal. The skin change is irritant dermatitis from urine, not candida. The stoma itself is healthy, with good spout height. Later problems to watch for are parastomal hernia, stomal stenosis or retraction, and peristomal skin overgrowth from chronic urine contact. [S]
- Kidney and metabolic effects of the ileal conduit (Z90.6). Reabsorption of chloride and ammonium from urine in the ileal segment causes hyperchloremic metabolic acidosis in some patients; his bicarbonate is at the lower limit. Kidney function can decline from infection, obstruction at the ureteric anastomoses, or reflux. Vitamin B12 deficiency is uncommon with the short segment used for a conduit, but yearly checks are advised from two to three years after surgery. [S]
- Urine findings with a conduit. Conduit urine is almost always colonized, and the dipstick and culture from the bag are usually abnormal. Bacteriuria without symptoms should not be treated. Fever, flank pain, rigors, or a rise in creatinine suggest upper-tract infection, which needs a culture taken by sterile catheter through the stoma and prompt treatment. [S]
- Retained urethra. The urethral margin was negative and the prostatic urethra was not involved, so the risk of urethral recurrence is low and routine urethral wash cytology is not needed; bloody discharge from the urethra should be reported. [S]
Data reviewed: Cystoscopy and resection pathology, the operative note and cystectomy pathology (pT2a, 0 of 18 nodes, margins negative), the pre-operative CT of the chest, abdomen, and pelvis with urography, and the first-visit chemistry, blood count, and vitamin B12. [S]
Plan of Treatment
- No adjuvant chemotherapy or immunotherapy. [S]
- CT of the chest, abdomen, and pelvis with a urographic phase at one year after surgery, then every 6 to 12 months to three years, then yearly; urology review with each scan. [S]
- Renal ultrasound at six months after surgery for hydronephrosis, then upper-tract imaging with each CT. [S]
- Chemistry with creatinine, chloride, and bicarbonate every 3 to 6 months in the first year, then yearly; start sodium bicarbonate 650 mg twice daily if bicarbonate falls below 22 mmol/L, or earlier for symptoms; vitamin B12 yearly from two to three years after surgery. [S]
- Stoma: convex wafer with a barrier ring, changed every three to four days, stoma powder and barrier film until the skin heals, and a night drainage bag; fitted today by the wound, ostomy, and continence nurse. [S]
- Do not culture or treat conduit urine without symptoms. For fever or flank pain, culture by catheter through the stoma and treat as a complicated urinary tract infection; check creatinine, and image the kidneys if fever persists beyond 48 to 72 hours. [S]
- About 2 liters of fluid a day; report blood from the stoma, flank pain, or a bulge around the stoma. [S]
- Erectile dysfunction after cystoprostatectomy: options (a PDE5 inhibitor, a vacuum device, or penile injections) explained; he does not want treatment now. [S]
- Discussed with Dr. Brandvold today. The patient agrees with the plan and has the stoma nurse's direct number. [S]
- Follow-up: Stoma nurse by telephone in one week. Urology review with the one-year CT, sooner for any problem. Primary care arranges the chemistry, the six-month ultrasound, and the yearly B12, and manages infections and acid-base. [S]